pembrolizumab,lenvatinib,sorafenib
merck,eisai,bayer
['hcc', 'bcsm', 'biomarker', 'leap-002']
important discussion of leap-002 by dr.katie kelly study - but impressive os in len arm- pfs consistent with reflect longer fu - what are best endpoints in hcc biomarkers needed #hpbcsm 
Medical Oncologist; clinical and translational researcher pancreatic and hepatobiliary cancers. Views are my own